Kyle Conley Email & Phone Number

Newton, Massachusetts, United States

Graticule is a digital CRO with technology to simplify secure and privacy controlled access to advanced real world data through an established research network of health systems and data aggregators. The company is founded on the premise that accessing and utilizing advanced datasets and integrating IRB approved research projects at health systems will bridge the “data to study gap” to unlock value for our clients. Life science solutions from Graticule include patient identification, FHIR interfaces to EHRs, and data sourcing of retrospective data for synthetic cohorts, biomarker discovery, or regulatory submissions.

Boston, Massachusetts, United States

Ceras Health is a digital first, integrated care provider combining clinical expertise, digital health devices, artificial intelligence, and behavioral change solutions to empower individuals to take control of their health and learn ways to extend and improve the quality of their lives. Ceras Health has developed a SaaS and mobile platform, that supports patients’ adherence to pre- and post-discharge care plans, provides patients and care team members with the ability to measure and track patient health data, and enables individuals to get better and stay better providing access to condition specific health information.

Newton, Ma

As one of the largest global clinical network, our singular aim is to improve the maturity and quality of insights with a 'living' Real World Evidence platform.From supporting clinical trials (site selection, data access, eSourcing, data linking, etc.) to care coordination to digital transformation to serving as a distribution layer for AI companies at scale across the patient's journey, Life Image continues to demonstrate hard metrics to shape the shift in healthcare from volume to value focusing on imaging, pathology and Genetics.By coalescing market leading partner ecosystem focused on DEMOCRATIZING data assets impacting patients, providers, care teams and payers across 1,700+ care delivery systems across US and 60,000+ international clinics, we are able to engage and influence how evidence collection and decision making is performed at country scale.We have connected together hundreds of academic medical centers, community hospitals, large integrated delivery networks, medical device companies, pharmaceuticals and telemedicine companies to orchestrate access, governance, archival, digitization and direct to patient engagement across long standing complex clinical workflows.

Lexington, Ma

ImmuneXcite is a privately held biotech company, that is developing the next generation of immune-activating anti-tumor biotherapeutics against a wide range of cancers using a fundamentally novel immunotherapy platform. The company’s mAbXcite platform develops novel therapies that recruit complement and neutrophils, the first responders of the immune system, to mount a natural and potent attack on cancer cells. ImmuneXcite has several lead drug candidates, based on its mAbXcite platform, for cancers with high unmet medical needs.

Boston, Ma

T1D Exchange is a non-profit organization dedicated to advance research in chronic diseases, facilitate greater industry collaboration, build a common registry based data exchange platform and bring together a community that allows better understanding of patient interactions. T1D will initially be targeted to address the Diabetes Type 1 market and build the nations first truely logitutinal exchange across all care modalities.Today the Exchange comprises of our provider network spanning 66 hospitals (AMC's and Community), bio-banking capabilities in collaboration with University of Washington and our innovation with a new approach to address patient community needs in the Type 1 space.T1D Exchange is funded by The Leona & Harry Helmsley Charitable Trust out of New York City and partnered with Jaeb Center for Health Research in Tampa, Florida.

Brighton, Massachusetts

Cambridge Biomedical is a specialized clinical research organization serving the diverse requirements of the biopharmaceutical/pharmaceutical and diagnostic markets, utilizing its multi-platform laboratory science capabilities and state-of-the-art systems and procedures to deliver timely, accurate results.Cambridge Biomedical provides clients with assay development, assay validation, and testing services in support of their clinical trial and pharmaceutical development objectives, serving as a trusted advisor to deliver value-added services and expertise to help advance breakthroughs in patient care.

Massachusetts, United States

A consulting firm that partnered with Venture Capitalists, Founders and CEOs in order to translate their strategic vision into operational reality. Enabling my clients to produce products, services or therapies for a healthier, cleaner, safer world.Specialties: Operations, Office Infrastructure, Human Resources, Benefits Administration, Facilities Management, Company Logistics, Meeting Planning, Purchasing, Health and Safety, Compliance and Logistics.

Surface Logix is a drug development company which uses its expertise in biophysical chemistry to create new small molecule drugs with significantly improved pharmacokinetic (PK) and pharmacodynamic (PD) properties compared with current class leaders.By using its proprietary chemistry platform – the Pharmacomer™ Technology Platform –Surface Logix creates New Chemical Entities (NCEs) that respond dynamically to the various physiological microenvironments in the human body. By enhancing molecular functionality, Surface Logix is able to solve PK and PD problems not addressable with traditional medicinal chemistry practices.

Cambridge, Massachusetts, United States

Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company, that markets VELCADE, a novel cancer product, and has a robust clinical development pipeline of product candidates. Millennium's research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of innovative product candidates.